NCT Heidelberg

What NCT Heidelberg does

NCT Heidelberg is a joint academic cancer center established in 2004 in Heidelberg, Germany, operated collaboratively by the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), Heidelberg University Medical Faculty, and Thoraxklinik Heidelberg. The center provides comprehensive oncology care across more than 20 specialized outpatient clinics covering major tumor types, integrating radiation therapy, medication therapy, immunotherapy, surgery, and clinical trial enrollment. It is designated an Oncology Center of Excellence (Onkologisches Spitzenzentrum) by Deutsche Krebshilfe.

Name

NCT Heidelberg

Legal name

National Center for Tumor Diseases (NCT) Heidelberg

Website

https://nct-heidelberg.de

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

101–250 employees

Short description

NCT Heidelberg is a joint academic cancer center in Heidelberg, Germany, providing comprehensive oncology care, translational research, and medical education across 20+ specialized outpatient clinics, serving cancer patients, referring physicians, and medical trainees.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Medical Laboratories (621511), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), General Medical and Surgical Hospitals (62211)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Oncology & Cancer Specialty Hospitals (HLAFAHAC), Clinical Research & Trial Central Laboratories (HLAFAMAL), Medical Oncology (HLAKAFAB)

Keywords

• Cancer treatment services
• Oncology center
• Precision oncology
• Clinical research
• Radiation therapy

Headquarters

HQ city

Heidelberg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Healthcare Service Reimbursement: Reimbursement through German public health insurance system (GKV/PKV) for covered medical treatments including radiation therapy, medication therapy, surgery, and clinical care.
2. Research Grants and Funding: Funding from German federal and state agencies including BMBF, DFG, as well as foundations such as Dietmar Hopp Stiftung, Deutsche Krebshilfe (DKH), and other cancer research funding bodies.
3. Donations and Charitable Contributions: Accepts donations through various channels including bank transfer, personal fundraising campaigns, memorial donations, bequests, and charity shopping. Benefits from charity events including NCT-Lauf (Run), Rudern gegen Krebs (Rowing), and Takte gegen Krebs (Music concerts).

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

NCT Heidelberg is a comprehensive cancer center providing integrated cancer diagnosis, treatment, and research services. It offers multimodal therapy including radiation therapy, medication therapy, surgery, and immunotherapy, supported by molecular precision oncology through the MASTER program. The center also delivers supportive care (psycho-oncology, nutrition, palliative care), clinical trial access, and medical education programs.

Product overview

NCT Heidelberg is a comprehensive cancer center offering integrated cancer treatment, research, and education services. The institution provides a full spectrum of treatment services including radiation therapy, medication therapy, immunotherapy, surgery, and clinical trials. Support services encompass physical activity programs (Netzwerk OnkoAktiv), nutrition counseling, psycho-oncology, palliative care, and social services. The research division includes Molecular Precision Oncology programs (MASTER, NCT POP), Core Services (Clinical Trial Center, Sample Processing Lab, Tissue Bank, Cancer Registry), and various specialized research areas. Education programs include the Elective Track Interdisciplinary Oncology, Fellowship Program, NCT Masterclass, and Practical Year rotations for medical students. Treatment is organized across multiple specialized cancer centers including Breast Cancer Center, Gynecological Oncology, Skin Tumor Center, Pediatric Oncology, Head Neck Cancer, Lung Cancer, Prostate Cancer, Sarcoma, Visceral Oncology (Colorectal, Stomach, Liver, Pancreatic, Esophageal), and Hematologic Neoplasms.

Differentiator

Problem solved

Functional benefit

Brands

• Netzwerk OnkoAktiv: Network for physical activity and exercise therapy for cancer patients
• NCT Cancer Registry
• MASTER Program
• Sozietät Czerny

Products and services

• Radiation Therapy Radiation oncology treatment services delivered as part of the comprehensive cancer care offerings for adult and pediatric oncology patients.
• Medication Therapy Medication-based cancer treatment services including chemotherapy and targeted therapies for oncology patients.
• Immunotherapy Immunotherapy treatment services offered to cancer patients as part of the multimodal treatment portfolio.
• Surgical Oncology Cancer surgery services performed within Heidelberg University Hospital departments in coordination with NCT Heidelberg.
• Clinical Trials Enrollment and conduct of oncology clinical trials spanning all phases, providing patients access to experimental and translational treatments.
• Multidisciplinary Tumor Board Multidisciplinary team review of individual patient cases for comprehensive treatment planning across oncology specialties.
• MASTER Molecular Precision Oncology Program Comprehensive molecular profiling program analyzing tumor genomes to guide personalized treatment decisions, including NCT POP for clinical translation of molecular findings.
• Netzwerk OnkoAktiv Exercise Therapy Germany-wide network of exercise therapy and physical activity programs for cancer patients, coordinated by NCT Heidelberg with partner facilities.
• Psycho-Oncology Service Psychological counseling and support services for cancer patients and their families during and after treatment.
• Palliative Medicine Palliative medicine and end-of-life care services for patients with advanced cancer diagnoses.
• Nutrition Counseling Nutritional counseling and dietary support services tailored for cancer patients during treatment and recovery.
• Smoking Consultation (Rauchersprechstunde)

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• German Cancer Research Center (DKFZ)coreStrategic or Co-development PartnerDKFZ is the national research center for cancer in Germany and serves as a primary supporting institution of NCT Heidelberg. Provides research infrastructure, scientific expertise, and translational research capabilities. The NCT was established as a joint institution with DKFZ as a founding partner alongside UKHD, Heidelberg University, and Thoraxklinik Heidelberg.
• Heidelberg University Hospital (UKHD)coreStrategic or Co-development PartnerUKHD is the clinical care partner in the NCT Heidelberg joint institution. Provides hospital facilities, clinical staff, and patient care infrastructure. Major clinical rotations for NCT programs occur in UKHD departments including Hematology, Radiooncology, and Internal Medicine.
• Heidelberg University (Universität Heidelberg)coreStrategic or Co-development PartnerThe Medical Faculty of Heidelberg University participates as a supporting institution, contributing academic research capabilities and medical education programs including the HeiCuMed medical curriculum and the Wahlfachtrack Interdisciplinary Oncology elective program.
• Thoraxklinik HeidelbergcoreStrategic or Co-development PartnerSpecialized thoracic oncology clinic serves as a partner institution for lung cancer treatment and research. Clinical rotations for NCT students and fellows include time at the Thoraxklinik for thoracic oncology experience.
• RocheminorStrategic or Co-development PartnerIndustrial collaboration between NCT Heidelberg and Roche focusing on pharmaceutical research and development in oncology. Part of NCT's industrial partnership program for translational cancer research.
• Cancer Core EuropeminorStrategic or Co-development PartnerEuropean cancer research network connecting major European cancer centers for collaborative research, data sharing, and clinical trial coordination. NCT Heidelberg participates as a member institution in this international partnership.
• Sozietät CzernyminorStrategic or Co-development PartnerHeidelberg Medical Faculty consortium for interdisciplinary medical education. NCT draws on existing structures of Sozietät Czerny for elective track courses in oncology. Czerny society members can participate in NCT elective courses.
• Network OnkoAktivminorChannel Partner/ Reseller/ DistributorGermany-wide network of exercise therapy and physical activity programs for cancer patients. NCT Heidelberg coordinates the network, which includes multiple cooperation centers across Germany delivering exercise oncology services to patients.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• European Institute of Oncology (IEO): IEO in Milan is one of Europe's largest standalone oncology institutions, offering similar precision medicine, surgery, and clinical research. It is a broader incumbent peer with comparable European footprint and academic medical center positioning.
• MD Anderson Cancer Center: MD Anderson is the global benchmark for comprehensive cancer centers with a comparable research-clinical integration model. While much larger and US-based, it represents the architectural incumbent peer that NCT Heidelberg's MASTER and translational programs are benchmarked against.

Direct peers

• Netherlands Cancer Institute (NKI): NKI is a leading European comprehensive cancer center with similar translational research, molecular profiling, and clinical trial programs. It is a direct peer within Cancer Core Europe for cross-border research collaboration and competitive clinical trial activation.
• Gustave Roussy Institute: Gustave Roussy is France's leading comprehensive cancer center and a fellow Cancer Core Europe member. It directly peers with NCT Heidelberg on cross-border precision oncology trials, virotherapy research, and pan-European clinical trial leadership.
• Charité Comprehensive Cancer Center: Charité's CCC in Berlin is one of Germany's leading comprehensive cancer centers, with similar precision oncology programs, clinical trial infrastructure, and DKFZ-affiliated research. It directly competes with NCT Heidelberg for national oncology leadership, pharma-sponsored trials, and top clinical talent.
• Vall d'Hebron Institute of Oncology (VHIO): VHIO is a leading Spanish comprehensive cancer center and a Cancer Core Europe member, with parallel precision oncology, early-phase trial, and translational research programs. It is a direct European peer competing for pharma-sponsored trial activation and molecular diagnostics leadership.
• LMU Klinikum – Comprehensive Cancer Center Munich: Munich's CCC (LMU/TU Munich) operates molecular precision oncology, immunotherapy, and comprehensive outpatient clinics similar to NCT Heidelberg. It is a direct peer for clinical trial leadership, precision oncology program development, and southern German patient referrals.
• University Hospital Tübingen – CCC Tübingen-Stuttgart: The Tübingen-Stuttgart CCC is a Baden-Württemberg-based comprehensive cancer center in the same German state as NCT Heidelberg. It directly competes for southern German patient referrals and DKH funding for precision oncology and translational programs.
• UCT Frankfurt (University Cancer Center Frankfurt): UCT Frankfurt is a designated Oncology Center of Excellence with comparable multidisciplinary tumor boards, molecular diagnostics, and translational research programs. It serves as a direct national peer competing for hematology/oncology referrals, trial patients, and research funding.
• Karolinska Comprehensive Cancer Center: Karolinska CCC in Stockholm is a fellow Cancer Core Europe member with comparable precision oncology and translational research programs. It directly peers with NCT Heidelberg on Nordic–Central European trial collaboration and oncology research leadership.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC779k72loO_c5S8zmbMDaMA
• Facebookfacebook.com/nctheidelberg
• LinkedInlinkedin.com/company/national-center-for-tumor-diseases-heidelberg
• Instagraminstagram.com/nct.heidelberg
• Xx.com/nct_hd

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NCT Heidelberg